NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…
Month: August 2024
NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…
NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS) and certain officers. The class action, filed in the United States District Court for the Southern District of New…
NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS) and certain officers. The class action, filed in the United States District Court for the Southern District of New…
NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) and certain officers. The class action, filed in the United States District Court for the District of…
NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) and certain officers. The class action, filed in the United States District Court for the District of…
NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Marinus Pharmaceuticals, Inc. (“Marinus” or the “Company”) (NASDAQ: MRNS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Marinus Pharmaceuticals, Inc. (“Marinus” or the “Company”) (NASDAQ: MRNS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against FAT Brands, Inc. (“Fat Brands” or the “Company”) (NASDAQ: FAT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Aug. 1, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against FAT Brands, Inc. (“Fat Brands” or the “Company”) (NASDAQ: FAT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…